Theseus Pharmaceuticals, Inc. logo

Theseus Pharmaceuticals, Inc.

NASDAQ:THRX

Overview | Financials
Company Name Theseus Pharmaceuticals, Inc.
Symbol THRX
Currency USD
Price 4.065
Market Cap 181,498,998
Dividend Yield 0%
52-week-range 2.05 - 12.37
Industry Biotechnology
Sector Healthcare
CEO Dr. Timothy P. Clackson Ph.D.
Website https://theseusrx.com

An error occurred while fetching data.

About Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation

Related Stocks

Akero Therapeutics, Inc. logo

Akero Therapeutics, Inc.

AKRO

28.89 USD

Icosavax, Inc. logo

Icosavax, Inc.

ICVX

15.31 USD

Kezar Life Sciences, Inc. logo

Kezar Life Sciences, Inc.

KZR

6.84 USD

Utah Medical Products, Inc. logo

Utah Medical Products, Inc.

UTMD

61.58 USD

Talaris Therapeutics, Inc. logo

Talaris Therapeutics, Inc.

TALS

2.72 USD

Aadi Bioscience, Inc. logo

Aadi Bioscience, Inc.

AADI

3.1 USD

Financials

Numbers are in millions USD

Numbers are in millions USD